| Literature DB >> 18276636 |
Zachary F Pursell1, J Tyson McDonald, Christopher K Mathews, Thomas A Kunkel.
Abstract
Replication of the mitochondrial genome by DNA polymerase gamma requires dNTP precursors that are subject to oxidation by reactive oxygen species generated by the mitochondrial respiratory chain. One such oxidation product is 8-oxo-dGTP, which can compete with dTTP for incorporation opposite template adenine to yield A-T to C-G transversions. Recent reports indicate that the ratio of undamaged dGTP to dTTP in mitochondrial dNTP pools from rodent tissues varies from approximately 1:1 to >100:1. Within this wide range, we report here the proportion of 8-oxo-dGTP in the dNTP pool that would be needed to reduce the replication fidelity of human DNA polymerase gamma. When various in vivo mitochondrial dNTP pools reported previously were used here in reactions performed in vitro, 8-oxo-dGTP was readily incorporated opposite template A and the resulting 8-oxo-G-A mismatch was not proofread efficiently by the intrinsic 3' exonuclease activity of pol gamma. At the dNTP ratios reported in rodent tissues, whether highly imbalanced or relatively balanced, the amount of 8-oxo-dGTP needed to reduce fidelity was <1% of dGTP. Moreover, direct measurements reveal that 8-oxo-dGTP is present at such concentrations in the mitochondrial dNTP pools of several rat tissues. The results suggest that oxidized dNTP precursors may contribute to mitochondrial mutagenesis in vivo, which could contribute to mitochondrial dysfunction and disease.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18276636 PMCID: PMC2367704 DOI: 10.1093/nar/gkn062
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Effect of equimolar 8-oxo-dGTP on the fidelity of wild type and exonuclease-deficient pol γ
| Exo-deficient pol γ | Wild-type pol γ | |
|---|---|---|
| Experiment 1: normal dNTPs only | ||
| Mut. Freq. (× 10−4) | 62 | 11 |
| Total sequenced mutants | 140 | 127 |
| Mutants with A to C | 0 | 0 |
| A to C rate (× 10−5) | ≤0.53 | ≤0.1 |
| Experiment 2: normal dNTPs + 8-oxo-dGTP | ||
| Mut. Freq. (× 10−4) | 720 | 500 |
| Total sequenced mutants | ND | 20 |
| Mutants with A to C | ND | 18 |
| A to C rate (× 10−5) | ND | 400 |
aTaken from (23).
8-oxo-dGTP effects with the highly imbalanced rat heart mitochondrial dNTP pools
| Exo-deficient pol γ | Wild-type pol γ | |
|---|---|---|
| Experiment 1: normal dNTPs only | ||
| Mut. Freq. (× 10−4) | 160 | 23 |
| Total sequenced mutants | 38 | 23 |
| Mutants with A to C | 1 | 1 |
| A to C rate (× 10−5) | 4.4 | 0.98 |
| Experiment 2: dNTPs + equimolar 8-oxo-dGTP (110 µM) | ||
| Mut. Freq. (× 10−4) | 5200 | 7700 |
| Total sequenced mutants | 24 | 69 |
| Mutants with A to C | 23 | 68 |
| A to C rate (× 10−5) | 4900 | 7400 |
| Experiment 3: dNTPs + 0.6% 8-oxo-dGTP (0.7 µM) | ||
| Mut. Freq. (× 10−4) | 520 | 390 |
| Total sequenced mutants | ND | 23 |
| Mutants with A to C | ND | 23 |
| A to C rate (× 10−5) | ND | 380 |
| Experiment 4: normal dNTPs + 0.06% 8-oxo-dGTP (0.07 µM) | ||
| Mut. Freq. (× 10−4) | 330 | 97 |
| Total sequenced mutants | 37 | 14 |
| Mutants with A to C | 17 | 11 |
| A to C rate (× 10−5) | 160 | 62 |
aA = 3.6 µM, T = 0.7 µM, C = 13 µM, G = 110 µM [from (23)].
bThese two values are not statistically different by Fisher's Exact Test.
8-oxo-dGTP effects on the fidelity of wild-type and exonuclease-proficient pol γ using slightly imbalanced dNTP pools reported in rodent liver
| Condition | Wild-type pol γ | |
|---|---|---|
| Experiment 1: normal dNTPs only | ||
| Mut. Freq. (× 10−4) | 12 | |
| Total sequenced mutants | 19 | |
| Mutants with A to C | 0 | |
| A to C rate (× 10−5) | ≤ 0.5 | |
| Experiment 2: dNTPs + 60% 8-oxo-dGTP (0.24 µM) | ||
| Mut. Freq. (× 10−4) | 160 | |
| Total sequenced mutants | 33 | |
| Mutants with A to C | 29 | |
| A to C rate (× 10−5) | 120 | |
| Experiment 3: dNTPs + 6% 8-oxo-dGTP (0.024 µM) | ||
| Mut. Freq. (× 10−4) | 27 | |
| Total sequenced mutants | 29 | |
| Mutants with A to C | 16 | |
| A to C rate (× 10−5) | 13 | |
| Experiment 4: dNTPs + 0.6% 8-oxo-dGTP (0.0024 µM) | ||
| Mut. Freq. (x 10−4) | 22 | |
| Total sequenced mutants | 23 | |
| Mutants with A to C | 4 | |
| A to C rate (x 10−5) | 3.3 | |
aA = 0.87 µM, T = 0.53 µM, C = 1.1 µM, G = 0.4 µM [adapted from (24)].
Figure 1.Resolution and detection of 8-oxo-dGTP by HPLC. The four panels depict HPLC elution profiles monitored by electrochemical detection. (A) Analysis of a rat liver mitochondrial extract. (B) Analysis of rat heart mitochondria. (C) Analysis of a rat liver mitochondrial extract; identical to panel A, except that 100 pmol of authentic 8-oxo-dGTP was present, after addition of standard to the mitochondria prior to extraction and analysis. (D) Analysis of rat skeletal muscle mitochondria. Each arrow points to a species eluted at about 40.2 min, identified as 8-oxo-dGTP by virtue of its coelution with the standard nucleotide.
Estimated intramitochondrial concentrations of dNTPs
| Tissue | Estimated intramitochondrial concentration, μM ± SD | ||||
|---|---|---|---|---|---|
| dATP | dTTP | dCTP | dGTP | 8-oxo-dGTP | |
| Liver | 1.7 ± 1.1 | 1.7 ± 1.5 | 3.9 ± 0.7 | 12.1 ± 5.9 | 1.2 ± 0.4 |
| Heart | 2.1 ± 1.5 | 3.2 ± 2.4 | 5.6 ± 2.8 | 69.3 ± 8.2 | 1.5 ± 1.2 |
| Brain | 3.5 ± 2.1 | 0.5 ± 0.2 | 2.8 ± 0.3 | 39.0 ± 0.2 | 0.4 ± 0.2 |
| Skeletal muscle | 1.6 ± 0.3 | 1.6 ± 2.5 | 4.5 ± 3.8 | 28.4 ± 5.8 | 0.2 ± 0.1 |
| Kidney | 2.4 ± 1.4 | 3.3 ± 3.8 | 5.7 ± 3.4 | 69.0 ± 63.8 | 1.7 ± 1.2 |
Data are averages of measurements with three adult male Wistar rats, with the exception of brain, which involved two measurements.
Figure 2.Estimation of adenine nucleotide levels in a rat liver mitochondrial extract. The figure shows an ultraviolet absorption profile (260 nm) obtained simultaneously with the electrochemical detection profile of a rat liver mitochondrial extract. The peaks corresponding to ATP, ADP and AMP were identified by analysis of standard nucleotide solutions.